Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Randomized, Multicenter, Double-Blind, Allopurinol-Controlled Study Assessing the Efficacy and Safety of Oral Febuxostat in Subjects With Gout.

NCT00430248 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT00430248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00430248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Randomized, Multicenter, Double-Blind, Allopurinol-Controlled Study Assessing the Efficacy and Safety of Oral Febuxostat in Subjects With Gout.
Lead sponsor
Takeda
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2007
Completion date
March 31, 2008
Enrollment
2,269 (actual)
Sites
258

Conditions

As the registry lists them; a condition with its own page is linked.

gout